{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:01:01Z","timestamp":1783033261425,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jfma.2024.10.010","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T22:41:16Z","timestamp":1729809676000},"page":"419-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015\u20132020"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5295-9997","authenticated-orcid":false,"given":"Tzu-Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1520-1166","authenticated-orcid":false,"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne Huey-Herng","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-6440","authenticated-orcid":false,"given":"Thung-Lip","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-1611","authenticated-orcid":false,"given":"Wei-Hsian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8249-7481","authenticated-orcid":false,"given":"Fang-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-475X","authenticated-orcid":false,"given":"Chau-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib1","first-page":"1","article-title":"Epidemiological features of cardiovascular disease in Asia","volume":"1","author":"Zhao","year":"2021","journal-title":"JACC (J Am Coll Cardiol): Asia"},{"issue":"10113","key":"10.1016\/j.jfma.2024.10.010_bib2","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"Abarca-G\u00f3mez","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib4","first-page":"4","article-title":"Guidelines of the taiwan society of cardiology on the diagnosis and management of chronic coronary syndrome","volume":"39","author":"Ueng","year":"2023","journal-title":"Acta Cardiol Sin"},{"issue":"25","key":"10.1016\/j.jfma.2024.10.010_bib5","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jfma.2024.10.010_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116513","article-title":"Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan","volume":"10","author":"Ho","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jfma.2024.10.010_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jfma.2016.11.013","article-title":"Taiwan lipid guidelines for high risk patients","volume":"116","author":"Li","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.jfma.2024.10.010_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijge.2012.09.001","article-title":"Registry of lipid control and the use of lipid-lowering drugs for secondary prevention of cardiovascular events in patients with established atherosclerotic disease in Taiwan: rationality and methods","volume":"6","author":"Yin","year":"2012","journal-title":"Int J Gerontol"},{"issue":"5","key":"10.1016\/j.jfma.2024.10.010_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4093\/dmj.2023.0135","article-title":"Dyslipidemia fact sheet in South Korea, 2022","volume":"47","author":"Jin ES","year":"2023","journal-title":"Diabetes Metab"},{"issue":"12","key":"10.1016\/j.jfma.2024.10.010_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075860","article-title":"Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China","volume":"13","author":"Chen","year":"2023","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.jfma.2024.10.010_bib12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.12567","article-title":"Trends in lipid concentrations and lipid control among US adults, 2007-2018","volume":"328","author":"Aggarwal","year":"2022","journal-title":"JAMA"},{"issue":"7810","key":"10.1016\/j.jfma.2024.10.010_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","author":"Taddei","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jfma.2024.10.010_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41430-020-00825-x","article-title":"The association of 14-year dietary cholesterol trajectories with the risk of cardio-metabolic diseases, all-cause mortality and serum lipids","volume":"75","author":"Hou","year":"2021","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12944-021-01450-8","article-title":"Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region","volume":"20","author":"Lee","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jfma.2024.10.010_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.839571","article-title":"Atherosclerotic cardiovascular disease risk and lipid-lowering therapy requirement in China","volume":"9","author":"Bi","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijge.2018.02.010","article-title":"Epidemiology of dyslipidemia in the Asia pacific region","volume":"12","author":"Lin","year":"2018","journal-title":"Int J Gerontol"},{"issue":"8","key":"10.1016\/j.jfma.2024.10.010_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jfma.2022.03.001","article-title":"Focused update of the 2017 Taiwan lipid guidelines for high risk patients: coronary artery disease, peripheral artery disease and ischemic stroke","volume":"121","author":"Chen","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12944-019-1158-5","article-title":"Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study","volume":"19","author":"Yang","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"5","key":"10.1016\/j.jfma.2024.10.010_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014150","article-title":"10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database","volume":"7","author":"Hsieh","year":"2017","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.jfma.2024.10.010_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182687","article-title":"Patterns of statin non-prescription in patients with established coronary artery disease: a report from a contemporary multicenter Japanese PCI registry","volume":"12","author":"Sawano","year":"2017","journal-title":"PLoS One"},{"issue":"10349","key":"10.1016\/j.jfma.2024.10.010_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.jfma.2024.10.010_bib24","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"Supplement_2","key":"10.1016\/j.jfma.2024.10.010_bib25","article-title":"Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab","volume":"43","author":"Michaeli","year":"2022","journal-title":"Eur Heart J"},{"issue":"10170","key":"10.1016\/j.jfma.2024.10.010_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jfma.2024.10.010_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/clc.22338","article-title":"Statins in the elderly: a patient-focused approach","volume":"38","author":"Wilmot","year":"2015","journal-title":"Clin Cardiol"},{"issue":"3s","key":"10.1016\/j.jfma.2024.10.010_bib28","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.je.2016.12.014","article-title":"Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan","volume":"27","author":"Yokomichi","year":"2017","journal-title":"J Epidemiol"},{"issue":"23","key":"10.1016\/j.jfma.2024.10.010_bib29","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1161\/CIR.0000000000001071","article-title":"Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American heart association","volume":"145","author":"Wenger","year":"2022","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.jfma.2024.10.010_bib30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jacc.2021.11.065","article-title":"Sex-specific considerations in the presentation, diagnosis, and management of ischemic heart disease: JACC focus seminar 2\/7","volume":"79","author":"Solola Nussbaum","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.jfma.2024.10.010_bib31","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jfma.2024.10.010_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jmii.2023.04.001","article-title":"How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020-2022","volume":"56","author":"Lai","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"33","key":"10.1016\/j.jfma.2024.10.010_bib33","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1093\/eurheartj\/ehac227","article-title":"The collateral damage of COVID-19 to cardiovascular services: a meta-analysis","volume":"43","author":"Nadarajah","year":"2022","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jfma.2024.10.010_bib34","first-page":"478","article-title":"Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study","volume":"101","author":"Wu","year":"2002","journal-title":"J Formos Med Assoc"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624004868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664624004868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:44:15Z","timestamp":1747734255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664624004868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0929664624004868"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.10.010","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015\u20132020","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}